A Life Sciences Matching Platform
A research publishing platform
that drives collaboration and partnering
Share your technology and research in a format investors can evaluate.
Match with VCs and pharmaceutical companies to drive collaboration and partnering.
Free to use during our early access period.
Free access is available until September 30, 2026. You will not be charged if you cancel before then.
Do any of these sound familiar?
You can’t keep your English
research materials up to date
You want to share your research
only with trusted organizations
You want to collaborate and
partner with overseas
VCs and pharma
How iDCP helps
Get your materials ready for overseas VCs and pharma
Based on your pitch deck and technical documents, we organize the questions you’re likely to face early on—
indication, differentiation, the preclinical/clinical roadmap, and the CMC path—and refine the story in English.
The goal is to create materials that move the conversation to the “next step.”
Share what you need—while protecting what matters
Execute an NDA within the platform to securely share confidential information.
Set disclosure levels step by step so you can balance speed and safety.
Meet overseas VCs and pharma
Your technology becomes searchable and recommended to investors and pharmaceutical companies worldwide.
This opens the door to collaboration and partnering opportunities.
How It Works
Register your technology
Start by sharing a document or website URL.
AI extracts the key points and drafts an English overview—also helping you build a foundation for an English data room.
Get contacted by investors and pharma
Your content becomes searchable and recommended.
Interested investors and pharmaceutical companies can reach out to you directly.
Chat, align, and set up meetings
Chat directly on the platform.
Organize due-diligence questions, coordinate meetings, and build momentum toward your next collaboration or partnering deal.
Getting Started
Sign up
You can sign up by clicking the "Sign Up" button on this page or via the link here. Follow the on-screen instructions to enter your organization and research information.
Review
After submitting your information, we’ll conduct a brief review. This may take a few business days.
Enter Payment Information
By entering your payment information, you will gain access to all features.
Currently available for free during the early access period.
The free period is available until September 30, 2026. If you cancel before this date, you can use the service at no cost.
Start Using iDCP
Register your technology and set your disclosure level.<br>You can start conversations with investors and pharmaceutical companies that match your interests.
FAQ
We've answered some frequently asked questions below.
If you have any further questions, please feel free to contact us.
iDCP is primarily designed for biotech startups and academic institutions. Any organization that wants to organize and share research data, papers, or slides in a format that global VCs and pharmaceutical companies can evaluate is welcome, regardless of size or industry.
We use the latest AI models, specialized in life sciences, to perform structuring and translation. Users can review, add, and revise the content themselves, ensuring accuracy for highly specialized research. Final adjustments are made by users to reflect their expertise.
After uploading your organization's URL and input data files, AI structuring and translation are completed within minutes to tens of minutes. You can then review, add, and edit the content as needed.
Yes. We activate iDCP by leveraging the science-focused community and expertise cultivated through iPark. Based on research content and objectives, we help create meaningful connections and collaboration opportunities.
All data is encrypted and managed under strict access controls. You can freely designate information as Confidential. Confidential information will not be disclosed to other users unless an individual NDA is executed on iDCP.